Register for email alerts and news feeds:
This journal | BMJ Group
rss
Drug and Therapeutics Bulletin 1996;34:25-27; doi:10.1136/dtb.1996.34425
Copyright © 1996 by the BMJ Publishing Group Ltd.

Pre-conception, pregnancy and prescribing

The thalidomide tragedy in the early 1960s demonstrated the extent of the damage that drugs can do to the fetus. The episode led to the introduction of licensing arrangements controlling manufacture, sale, supply and marketing of drugs1 and it is now rare for a licence application for a new drug to include a recommendation for its use in pregnancy. The British National Formulary warns that "no drug is safe beyond all doubt in early pregnancy". Pregnant women nonetheless may need drug treatment. In this article we consider what precautions the prescriber should take to ensure that the risk to the fetus is minimised while not denying women of child-bearing age effective therapy.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for email alerts

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Coming soon!

The DTB archive back to 1962, volume 1, issue 1 will soon be available.